Supporting Healthy Aging

Supporting Healthy Aging

Healthy Aging

Living a long and healthy life is usually at the top of list when it comes to most people’s life goals. The good news is that today more people are living longer than ever before. The bad news is that society is not as prepared as it probably should be for the demographic shift we will see over the next 20 years.

In 2018, the World Bank noted that the number of seniors (65+) totaled more than 650 million1, double the amount from 30 years ago. Over the next three decades, projections demonstrate that the number of seniors is set to more than double again to more than 1.6 billion by 2050.

According to the World Health Organization (WHO) society is a critical point in time to prepare for its inevitable future. If we get it right, the next 10 years is our opportunity. Dubbed the Decade of Healthy Aging, the WHO views the next ten years an opportunity for society to come together to advance innovative solutions that can help improve the lives of elderly persons across the globe.

As a long-standing champion of self-care, maker of innovative medicines and a strong supporter of healthy aging, Bayer was proud to participate in the recent Global Aging Summit that took place in Toronto, Ontario. The event from September 17-19 brought close to 1,000 global delegates together to discuss aging policy. Everything from innovative treatments, to housing design and service delivery was on the agenda.

Bayer aging suit

An aging suit is used by Bayer at the Global Aging Summit 2019 to demo three major external perceptions: loss of mobility/dexterity, loss of strength/muscle power and loss of vision.

Shurjeel Choudhri

“Bayer has always been a proud, solutions oriented company focused on cross-collaboration and partnership,” said Shurjeel Choudhri, Senior Vice President and Head of Medical and Scientific Affairs for Bayer Canada. “Through this event we not only got to highlight some of the work we are doing and how others can get involved, but we also had the opportunity engage in important conversations about the work our peers are doing the world over. It was great to be a part of this.”

Through the event, Bayer highlighted its open innovation agenda, which works with start-ups and innovators to help advance their ideas. The company also profiled its aging simulation suit that replicates three age related health challenges: loss of mobility/dexterity, loss of strength/muscle power, and vision loss.

“As we look to advance future policy, it is critical that we understand the needs of our older citizens,” added Choudhri. “Our aging simulation suit offers us a glimpse into some of the more common health challenges we face as we age, and therefore offers a great opportunity to get more in touch with the needs of seniors.”

Footnote